SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-04
👔
GALECTIN THERAPEUTICS INC
@GALT_InsiderForm 4 Filing: Uihlein Richard E Exercises Options for $105.8M of $GALT
OPTION EXERCISE
⚡ MATERIALITY: 7/10
corporate issuer
GALECTIN THERAPEUTICS INC
Ticker: $GALT
Transaction Value
$105.8M
Price/Share: $3.08
transaction date
2026-07-31
Shares: 34,376,167
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Uihlein Richard E, holds the title of Director at GALECTIN THERAPEUTICS INC.
On 2026-07-31, the insider transacted 34,376,167 shares.The shares were transacted at a weighted average price of $3.08 per share, resulting in a total market-relevant value of $105.8M.
Executive Summary Summary
Uihlein Richard E (Director) exercised options for $105.8M of $GALT
Post-Transaction Position: 42,162,911 shares
SEC Accession No: 0001133416-26-000065 (CIK: 1694903)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.